X

Health Care

CVS Health raises guidance for FY25 revenue and adjusted earnings

Healthcare services company CVS Health (NYSE: CVS) has updated its 2025 full-year financial guidance and issued forecasts for fiscal 2026.…

IPO News: What to look for when Lumexa Imaging goes public

IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in…

Earnings Summary: CooperCompanies reports higher Q4 revenue, adj. profit

CooperCompanies (NYSE: COO) has reported an increase in revenues and adjusted earnings for the fourth quarter of fiscal 2025. The…

MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings for the second quarter of…

Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO

CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on…

Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance

Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter of fiscal 2025, and updated…

Earnings Summary: Humana Q3 2025 profit drops despite higher revenues

Humana Inc. (NYSE: HUM), a leading health and well-being company, on Wednesday reported a decline in adjusted earnings for the…

Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report

Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third…

PFE Earnings: All you need to know about Pfizer’s Q3 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings results today. Revenues were $16.7 billion, down 6% on a…

Earnings Summary: Highlights of IDEXX’s Q3 2025 report

Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and earnings for the third quarter of…